MMR and Autism Meeting Agenda
Washington DC
March 8, 2001

PLEASE NOTE:
Online presentations from the MMR and Autism meeting are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read here.

For best results, use Internet Explorer to view slides. The audiocast segments require RealPlayer. Click here to download RealPlayer 8 Basic for free.


SESSION I: ETIOLOGY, DIAGNOSIS, AND EPIDEMIOLOGY OF AUTISM

Opening Remarks
Marie McCormick, MD, ScD
Chair, Immunization Safety Review Committee
Audio

Neurobiology and neuropathology of autism
Thomas Kemper, MD Professor
Department of Neurology, Anatomy, and Pathology
Boston University School of Medicine
Handout
Audio
Questions for Dr. Kemper

Etiology of autism and NIH research
Marie Bristol-Power, PhD Special Assistant on Autism
Office of the Director, NICHD
National Institutes of Health
Slides
Audio
Questions for Dr. Bristol-Power

Diagnosis and assessment of autism
Fred Volkmar, MD Professor of Child Psychiatry, Pediatrics, and Psychology
Yale Child Study Center
Audio
Questions for Dr. Volkmar

Epidemiological evidence on rates of autism and time trends
Eric Fombonne, MD, FRCPsych Reader in Epidemiological Child Psychiatry
Institute of Psychiatry
King's College London
Slides
Audio 
Questions for Dr. Fombonne

Trends in students with autism in IDEA programs
Louis Danielson, PhD Director of Research to Practice Division
Office of Special Education Programs
Department of Education
Audio
Questions for Dr. Danielson

Discussion

Discussion Panel:
Kathryn Carbone, MD
Chief, Laboratory of Pediatric and Respiratory Viral Diseases
DVP/OVRR/CBER/FDA
Audio

Ezra Susser, MD
Head, Division of Epidemiology
Joseph L. Mailman School of Public Health
Columbia University
Audio

Karin Nelson, MD Senior Investigator, Neuroepidemiology BranchNational Institute for Neurological Disorders and Stroke
National Institutes of Health
Handout
Audio
Questions for the Panel

SESSION II: MMR/ IBD/ AUTISM HYPOTHESIS

Hypothesis and data linking MMR/IBD/autism
Andrew Wakefield, MD
Royal Free & University College Medical School, United Kingdom
Slides
Audio

Kenneth Aitken, Ph.D.
Independent Consultant Child Clinical Neuropsychologist
Audio
Questions for Drs. Wakefield and Aitken

Overview of epidemiological studies examining MMR, IBD, and autism
Michael Stoto, PhD
Chair, Department of Epidemiology and Biostatistics
George Washington University
Slides
Audio
Questions for Dr. Stoto

New data and research findings regarding the link between MMR, bowel symptoms, and autism
Eric Fombonne, MD, FRCPsych Reader in Epidemiological Child Psychiatry
Institute of Psychiatry
King's College London
Slides unavailable
Audio
Questions for Dr. Fombonne

Discussion
Discussion Panel:
Scott Montgomery, PhDKarolinska Institute, Sweden
Audio

Brian Ward, MD
Associate Professor (Medicine & Microbiology), McGill University and Montreal General Hospital Research Institute
Audio

Michael Gershon, MD
Professor and Chair, Department of Anatomy and Cell Biology
Columbia University
Audio

Kathryn Carbone, MD
Chief, Laboratory of Pediatric and Respiratory Viral Diseases
DVP/OVRR/CBER/FDA
Audio

Karin Nelson, MD Senior Investigator, Neuroepidemiology BranchNational Institute for Neurological Disorders and Stroke
National Institutes of Health
Audio 
Questions for the Panel

Study of autism and the Vaccine Adverse Event Reporting System (VAERS)
Jane Woo, MD, MPH
Fellow, Vaccine Safety Branch
Division of Epidemiology
OBE/CBER/FDA
Slides
Audio
Questions for Dr. Woo

Public Comment Session
Audio




Back to the Immunization Safety Review Committee Homepage

Page last updated May 30, 2003